STXS
Stereotaxis, Inc.
$1.84
+1.10%
$179.8M
No data for this timeframe.
Vol
Market Cap$179.8M
Cap SizeMicro Cap
Analyst ConsensusStrong Buy (90%)
Inst. Holders46 funds
Inst. Value$27.0M
Inst. Activity3 buys / 6 sells
SEC Reports7
Press Releases2
Exchange NYSE·Sector Electromedical & Electrotherapeutic Apparatus·Inc. DE·CIK 0001289340·Prev Close $1.82
Recent Activity
May 12, 2026
SEC
Stereotaxis reported Q1 2026 revenue of $6.3M, down 16% YoY from $7.5M, and a GAAP net loss per share of -$0.06, in line
8-K — Impact 6/10
May 12, 2026
SEC
Stereotaxis reported Q1 2026 revenue of $6.3M (down 16% YoY from $7.5M) and EPS of -$0.06, missing the consensus estimat
PRESS-RELEASE — Impact 6/10
Apr 21, 2026
SEC
Stereotaxis announced a future earnings release date for Q1 2026, with no financial results or guidance provided in this
PRESS-RELEASE — Impact 3/10
Apr 11, 2026
Insider
Peery Kimberly R. was granted 40,000 shares
Chief Financial Officer
Inst.
SEI INVESTMENTS CO — DOUBLED
518,884 shares ($954.7K)
Inst.
MORGAN STANLEY — TRIM
130,803 shares ($240.7K)
May 12, 2026
earnings
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
<p align="justify">ST. LOUIS, May 12, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.
Apr 15, 2026
Press
Stereotaxis (STXS) announced a definitive agreement to acquire Robocath, a French innovator in robotic interventional ca
Impact 7/10
Price Targets
$4.13
+124.2% upside
Strong Buy
Current $1.84
Low $3.50
Median $4.00
High $5.00
4 analysts
$3.50
$5.00
Analyst Ratings
2Strong Buy
7Buy
1Hold
0Sell
0Strong Sell
Recent Analyst Actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| May 13, 2026 | Piper Sandler | REITERATE | Overweight → Overweight |
| Dec 16, 2025 | Citizens | INITIATE | Market Outperform |
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current Q | $-0.05 ▲ +11.1% | $-0.06 — $-0.03 | 7% YoY | 3 |
| Next Q | $-0.05 ▼ -16.7% | $-0.06 — $-0.04 | 33% YoY | 3 |
| Current FY | $-0.19 ▼ -2.7% | $-0.23 — $-0.17 | 24% YoY | 3 |
| Next FY | $-0.13 ▼ -3.4% | $-0.18 — $-0.07 | 33% YoY | 3 |
Latest Reports
BEARISH
8-K
6/10
Stereotaxis reported Q1 2026 revenue of $6.3M, down 16% YoY from $7.5M, and a GAAP net loss per share of -$0.06, in line
May 12, 2026
MIXED
PRESS-RELEASE
6/10
Stereotaxis reported Q1 2026 revenue of $6.3M (down 16% YoY from $7.5M) and EPS of -$0.06, missing the consensus estimat
May 12, 2026
BULLISH
Press
7/10
Stereotaxis (STXS) announced a definitive agreement to acquire Robocath, a French innovator in robotic interventional ca
Apr 15, 2026
Top Institutional Holders
| Fund | Value | Move |
|---|---|---|
| BlackRock, Inc. | $7.3M | — |
| VANGUARD CAPITAL MANAGEMENT LLC | $5.5M | — |
| Arbiter Partners Capital Management | $5.3M | — |
| STATE STREET CORP | $1.8M | — |
| VANGUARD FIDUCIARY TRUST CO | $975.0K | — |
Recent Insider Trades
| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 11, 2026 | Peery Kimberly | A | $0.00 |
46 institutional holders with $27.0M total value (14,799,723 shares) as of 2026-Q1. Top holders: BlackRock,, VANGUARD, Arbiter. Net selling activity: 6 institutions trimmed/exited vs 3 added.
Top Institutional Holders — 2026-Q1
| # | Fund | Shares | Value | % of Tracked | Last Move |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 3,956,243 | $7.3M | 26.9% | — |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 2,998,044 | $5.5M | 20.4% | — |
| 3 | Arbiter Partners Capital Management LLC | 2,883,856 | $5.3M | 19.6% | — |
| 4 | STATE STREET CORP | 957,768 | $1.8M | 6.5% | — |
| 5 | VANGUARD FIDUCIARY TRUST CO | 529,870 | $975.0K | 3.6% | — |
| 6 | SEI INVESTMENTS CO | 518,884 | $954.7K | 3.5% | DOUBLED +108.9% |
| 7 | RENAISSANCE TECHNOLOGIES LLC | 372,600 | $685.6K | 2.5% | DOUBLED +768.5% |
| 8 | VANGUARD PORTFOLIO MANAGEMENT LLC | 368,629 | $678.3K | 2.5% | — |
| 9 | GOLDMAN SACHS GROUP INC | 269,046 | $495.0K | 1.8% | — |
| 10 | CAPTRUST FINANCIAL ADVISORS | 221,020 | $406.7K | 1.5% | — |
| 11 | Independent Advisor Alliance | 200,985 | $369.8K | 1.4% | — |
| 12 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 172,747 | $317.9K | 1.2% | — |
| 13 | ROYAL BANK OF CANADA | 161,183 | $297.0K | 1.1% | ADD +68.9% |
| 14 | ENVESTNET ASSET MANAGEMENT INC | 135,772 | $249.8K | 0.9% | ADD +47.3% |
| 15 | RHUMBLINE ADVISERS | 132,353 | $243.5K | 0.9% | DOUBLED +223.7% |
| 16 | MORGAN STANLEY | 130,803 | $240.7K | 0.9% | TRIM -31.8% |
| 17 | Nuveen, LLC | 73,990 | $136.1K | 0.5% | — |
| 18 | HSBC HOLDINGS PLC | 68,605 | $124.9K | 0.5% | ADD +65.1% |
| 19 | BARCLAYS PLC | 67,826 | $124.8K | 0.5% | ADD +38.4% |
| 20 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 50,384 | $92.7K | 0.3% | — |
Recent Position Changes
| Fund | Action | Prev Shares | Curr Shares | Change % | Value | Quarter |
|---|---|---|---|---|---|---|
| SEI INVESTMENTS CO | DOUBLED | 248,441 | 518,884 | +108.9% | $954.7K | 2026-Q1 |
| MORGAN STANLEY | TRIM | 191,848 | 130,803 | -31.8% | $240.7K | 2026-Q1 |
| BANK OF AMERICA CORP /DE/ | TRIM | 90,628 | 49,747 | -45.1% | $91.5K | 2026-Q1 |
| FMR LLC | TRIM | 41,147 | 28,960 | -29.6% | $53.3K | 2026-Q1 |
| CWM, LLC | DOUBLED | 1,880 | 4,988 | +165.3% | $9.2K | 2026-Q1 |
| NISA INVESTMENT ADVISORS, LLC | TRIM | 11,023 | 2,794 | -74.7% | $5.1K | 2026-Q1 |
| GROUP ONE TRADING LLC | TRIM | 10,588 | 2,742 | -74.1% | $5.0K | 2026-Q1 |
| DEUTSCHE BANK AG\ | NEAR_EXIT | 51,584 | 1,016 | -98.0% | $1.9K | 2026-Q1 |
| Allworth Financial LP | DOUBLED | 14 | 246 | +1657.1% | $453.00 | 2026-Q1 |
| MORGAN STANLEY | ADD | 117,728 | 191,848 | +63.0% | $441.3K | 2025-Q4 |
| BANK OF AMERICA CORP /DE/ | ADD | 63,114 | 90,628 | +43.6% | $208.4K | 2025-Q4 |
| TWO SIGMA INVESTMENTS, LP | NEAR_EXIT | 361,888 | 67,729 | -81.3% | $155.8K | 2025-Q4 |
| WELLS FARGO & COMPANY/MN | ADD | 38,331 | 66,452 | +73.4% | $152.8K | 2025-Q4 |
| FMR LLC | ADD | 21,953 | 41,147 | +87.4% | $94.6K | 2025-Q4 |
| MARSHALL WACE, LLP | TRIM | 125,804 | 37,898 | -69.9% | $87.2K | 2025-Q4 |
| PNC FINANCIAL SERVICES GROUP, INC. | TRIM | 28,119 | 17,181 | -38.9% | $39.5K | 2025-Q4 |
| NISA INVESTMENT ADVISORS, LLC | ADD | 8,229 | 11,023 | +34.0% | $25.4K | 2025-Q4 |
| GROUP ONE TRADING LLC | TRIM | 18,096 | 10,588 | -41.5% | $24.4K | 2025-Q4 |
| RENAISSANCE TECHNOLOGIES LLC | DOUBLED | 43,800 | 380,400 | +768.5% | $1.2M | 2025-Q3 |
| MORGAN STANLEY | TRIM | 183,022 | 117,728 | -35.7% | $366.1K | 2025-Q3 |
| HSBC HOLDINGS PLC | ADD | 41,547 | 68,606 | +65.1% | $209.9K | 2025-Q3 |
| WELLS FARGO & COMPANY/MN | ADD | 30,045 | 38,331 | +27.6% | $119.2K | 2025-Q3 |
| GROUP ONE TRADING LLC | DOUBLED | 1,439 | 18,096 | +1157.5% | $56.3K | 2025-Q3 |
| Russell Investments Group, Ltd. | DOUBLED | 1,232 | 5,865 | +376.1% | $18.2K | 2025-Q3 |
| ROYAL BANK OF CANADA | ADD | 155,918 | 263,410 | +68.9% | $559.0K | 2025-Q2 |
1 unique insiders with 1 transactions. Net insider value: $0.00 ($0.00 bought, $0.00 sold).
Insider Transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Apr 11, 2026 | Peery Kimberly R. | Chief Financial Officer | AWARD | 40,000 | — | — |
7 SEC filing reports analyzed. Sentiment: 0 bullish, 2 bearish, 2 mixed, 3 neutral. Avg impact: 4.9/10.
BEARISH
8-K
6/10
Stereotaxis reported Q1 2026 revenue of $6.3M, down 16% YoY from $7.5M, and a GAAP net loss per shar
May 12, 2026
MIXED
PRESS-RELEASE
6/10
Stereotaxis reported Q1 2026 revenue of $6.3M (down 16% YoY from $7.5M) and EPS of -$0.06, missing t
May 12, 2026
NEUTRAL
PRESS-RELEASE
3/10
Stereotaxis announced a future earnings release date for Q1 2026, with no financial results or guida
Apr 21, 2026
MIXED
8-K
6/10
Stereotaxis is acquiring French robotics firm Robocath for $20 million upfront plus up to $25 millio
Apr 15, 2026
NEUTRAL
DEFA14A
3/10
Stereotaxis, Inc. filed a definitive proxy statement (DEFA14A) for its upcoming shareholder meeting,
Apr 3, 2026
NEUTRAL
EFFECT
4/10
Stereotaxis, Inc. has filed an EFFECT notice indicating that its shelf registration statement on For
Mar 23, 2026
BEARISH
S-3
6/10
Stereotaxis filed an S-3 shelf registration to potentially raise up to $150 million, combining a new
Mar 13, 2026
Current analyst consensus: Strong Buy (90% buy). Based on 10 analysts: 2 strong buy, 7 buy, 1 hold, 0 sell, 0 strong sell.
Analyst Price Targets
$4.13 mean target
+124.2% upside
Strong Buy (1.50)
$3.50 Low
$5.00 High
| Metric | Value |
|---|---|
| Current Price | $1.84 |
| Target Low | $3.50 |
| Target Mean | $4.13 |
| Target Median | $4.00 |
| Target High | $5.00 |
| # Analysts | 4 |
| Recommendation | Strong Buy (1.50) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q 2026-06-30 |
$-0.05 | $-0.06 | $-0.03 | 6.7% | +11.1% | 1↑ 0↓ | $0.0B | -5.1% | 3 |
| Next Q 2026-09-30 |
$-0.05 | $-0.06 | $-0.04 | 33.3% | -16.7% | 0↑ 1↓ | $0.0B | 47.0% | 3 |
| Current FY 2026-12-31 |
$-0.19 | $-0.23 | $-0.17 | 24.0% | -2.7% | 0↑ 1↓ | $0.0B | 21.7% | 3 |
| Next FY 2027-12-31 |
$-0.13 | $-0.18 | $-0.07 | 33.3% | -3.4% | 0↑ 1↓ | $0.1B | 35.2% | 3 |
Current Quarter EPS Revision History
| Timepoint | EPS Estimate | Change |
|---|---|---|
| Current | $-0.047 | |
| 7d ago | $-0.052 | +0.006 |
| 30d ago | $-0.052 | +0.006 |
| 60d ago | $-0.052 | +0.006 |
| 90d ago | $-0.057 | +0.010 |
2 analyst firms have rated this stock: 0 upgrades, 0 downgrades, 1 initiations.
Individual Analyst Actions
| Date | Analyst Firm | Action | Previous Rating | New Rating |
|---|---|---|---|---|
| May 13, 2026 | Piper Sandler | REITERATE | Overweight | Overweight |
| Dec 16, 2025 | Citizens | INITIATE | — | Market Outperform |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 2 | 7 | 1 | 0 | 0 | 90% | |
| May 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Apr 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Mar 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Feb 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% | |
| Jan 1, 2026 | 2 | 8 | 1 | 0 | 0 | 91% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
No Reddit sentiment data available yet. Sentiment is analyzed from Reddit investment communities on a rolling basis.
May 12, 2026
earnings
Stereotaxis Reports 2026 First Quarter Financial Results & Business Updates
<p align="justify">ST. LOUIS, May 12, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=2pZ5p0tV9VmbHdG7AP9_TugdOsxT4AN4o
May 12, 2026
earnings_calendar
STXS Q1 2026 Earnings After Market Close — 2026-05-12
Apr 22, 2026
other
Stereotaxis Announces First MAGiC Procedures in the United States
<p align="justify">ST. LOUIS, April 22, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for mini
Apr 21, 2026
earnings
Stereotaxis to Report First Quarter 2026 Financial Results on May 12, 2026
<p>ST. LOUIS, April 21, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=aFHeGYVL4IVkW6_hiMBCSA96YnptKBHiBTale0adty4CUys
Apr 15, 2026
m_and_a
Stereotaxis Announces Definitive Agreement to Acquire Robocath
<p align="justify">ST. LOUIS and ROUEN, France, April 15, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=HPlOpY4plg9UR
Apr 6, 2026
fda
Stereotaxis Announces FDA Clearance and Launch of Synchrony System
<p align="justify">ST. LOUIS, April 06, 2026 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for mini
Mar 9, 2026
earnings
Stereotaxis Reports 2025 Full Year Financial Results
<p align="justify">ST. LOUIS, March 09, 2026 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=Fkdcv1-diVOdexz6AdOY6Bc2TMWNKim
Mar 9, 2026
earnings_calendar
STXS Q4 2025 Earnings After Market Close — 2026-03-09